Salem Investment Counselors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4
| Closed | -$69 | – | 1216 |
|
|
2024
Q2 | $69 | Hold |
4
| – | – | ﹤0.01% | 1151 |
|
|
2024
Q1 | $63 | Hold |
4
| – | – | ﹤0.01% | 1157 |
|
|
2023
Q4 | $60 | Hold |
4
| – | – | ﹤0.01% | 1097 |
|
|
2023
Q3 | $65 | Sell |
4
-85
| -96% | -$1.38K | ﹤0.01% | 1088 |
|
|
2023
Q2 | $3.69K | Buy |
89
+10
| +13% | +$415 | ﹤0.01% | 950 |
|
|
2023
Q1 | $4.75K | Hold |
79
| – | – | ﹤0.01% | 915 |
|
|
2022
Q4 | $5.8K | Hold |
79
| – | – | ﹤0.01% | 865 |
|
|
2022
Q3 | $6K | Hold |
79
| – | – | ﹤0.01% | 846 |
|
|
2022
Q2 | $5K | Hold |
79
| – | – | ﹤0.01% | 886 |
|
|
2022
Q1 | $7K | Hold |
79
| – | – | ﹤0.01% | 812 |
|
|
2021
Q4 | $6K | Buy |
79
+4
| +5% | +$304 | ﹤0.01% | 908 |
|
|
2021
Q3 | $9K | Hold |
75
| – | – | ﹤0.01% | 777 |
|
|
2021
Q2 | $17K | Hold |
75
| – | – | ﹤0.01% | 648 |
|
|
2021
Q1 | $10K | Hold |
75
| – | – | ﹤0.01% | 676 |
|
|
2020
Q4 | $13K | Hold |
75
| – | – | ﹤0.01% | 617 |
|
|
2020
Q3 | $8K | Buy |
+75
| New | +$8K | ﹤0.01% | 578 |
|